MSF doctor Dr. Maham Khalid is examining four-year-old Ahmad during a consultation at the MSF-supported Programmatic Management of Drug-Resistant Tuberculosis (PMDT) site in Gujranwala, Punjab.

Photo Credit: Gul Nayab

Press release |

24 March 2026

MSF demands sustained investments and political will to end neglect of children with tuberculosis

1.2 million children have TB worldwide, but nearly half miss diagnosis and treatment

TUBERCULOSIS

Read more

Photo Credit: Gul Nayab

Issue brief |

09 April 2026

AfricaKenyaRwandaSouth Africa

Shifting Global Health R&D Funding: Opportunities in a Changing Landscape

Press release |

30 March 2026

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

In an open letter published today, Doctors Without Borders/Médecins Sans Frontières (MSF) called on the US pharmaceutical corporation Gilead Sciences to immediately sell the organization the game-changing and highly effective HIV prevention medicine, lenacapavir, for use in its medical programs worldwide. Despite multiple requests, the company has refused to sell lenacapavir directly to MSF.

Feature story |

27 March 2026

A mother’s journey: Caring for her children with drug-resistant TB

Issue brief |

26 March 2026

EthiopiaNigeriaSouth Sudan

Antimicrobial Resistance in Conflict-Affected Settings: Field Realities, Operational Challenges & Policy Insights

Interview |

24 March 2026

How TB Treatment Decision Algorithms Help Diagnose Children: A Paediatrician’s Experience

Statement |

20 March 2026

MSF statement at IGWG6

Press release |

19 March 2026

MSF calls on EU to unlock progress in final Pandemic Agreement talks

Letter |

16 March 2026

Open letter: The Critical Medicines Act must deliver equitable, affordable access to medicines for all

Press release |

05 March 2026

DNP+ and MSF welcome the removal of harmful IP provisions in EU-India FTA , but call for continued vigilance

Technical brief |

09 February 2026

Ensuring Collective Efforts Deliver Equitable Access Through the WHO PABS System

Events |

06 February 2026

MSF statements at WHO Executive Board 158th session

Statement |

16 December 2025

Governments must take concrete actions to ensure equitable access to medical tools for noncommunicable diseases and mental health conditions

Maria Atonio, 43-years-old farmer from Macomia, returns home after visiting MSF’s Clinic in Nanga to receive ART treatment and to have a medical appointment with MSF’s clinical officer to monitor her health.

Photo credit: MSF/Martim Gray Pereira

Press release |

19 March 2026

MSF calls on EU to unlock progress in final Pandemic Agreement talks

EU must guarantee access to medical tools for communities sharing pathogens and data

PANDEMIC PREPAREDNESS RESEARCH AND DEVELOPMENT

Read more

Photo credit: MSF/Martim Gray Pereira

Issue brief |

09 April 2026

AfricaKenyaRwandaSouth Africa

Shifting Global Health R&D Funding: Opportunities in a Changing Landscape

Press release |

30 March 2026

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

In an open letter published today, Doctors Without Borders/Médecins Sans Frontières (MSF) called on the US pharmaceutical corporation Gilead Sciences to immediately sell the organization the game-changing and highly effective HIV prevention medicine, lenacapavir, for use in its medical programs worldwide. Despite multiple requests, the company has refused to sell lenacapavir directly to MSF.

Feature story |

27 March 2026

A mother’s journey: Caring for her children with drug-resistant TB

Issue brief |

26 March 2026

EthiopiaNigeriaSouth Sudan

Antimicrobial Resistance in Conflict-Affected Settings: Field Realities, Operational Challenges & Policy Insights

Press release |

24 March 2026

MSF demands sustained investments and political will to end neglect of children with tuberculosis

Interview |

24 March 2026

How TB Treatment Decision Algorithms Help Diagnose Children: A Paediatrician’s Experience

Statement |

20 March 2026

MSF statement at IGWG6

Letter |

16 March 2026

Open letter: The Critical Medicines Act must deliver equitable, affordable access to medicines for all

Press release |

05 March 2026

DNP+ and MSF welcome the removal of harmful IP provisions in EU-India FTA , but call for continued vigilance

Technical brief |

09 February 2026

Ensuring Collective Efforts Deliver Equitable Access Through the WHO PABS System

Events |

06 February 2026

MSF statements at WHO Executive Board 158th session

Statement |

16 December 2025

Governments must take concrete actions to ensure equitable access to medical tools for noncommunicable diseases and mental health conditions

MSF bio lab at MSF’s Aden hospital controls and treats the anti-resistant infected cases. Aden-The Bio lab project was launched as part of the medical lab at MSF Aden hospital southern Yemen, on January 2017.

Photograph by Ehab Zawati/MSF

Technical brief |

09 February 2026

Ensuring Collective Efforts Deliver Equitable Access Through the WHO PABS System

MSF recommendations on WHO Pathogen Access and Benefit-Sharing (PABS) systems

PANDEMIC PREPAREDNESS

Read more

Photograph by Ehab Zawati/MSF

Issue brief |

09 April 2026

AfricaKenyaRwandaSouth Africa

Shifting Global Health R&D Funding: Opportunities in a Changing Landscape

Press release |

30 March 2026

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

In an open letter published today, Doctors Without Borders/Médecins Sans Frontières (MSF) called on the US pharmaceutical corporation Gilead Sciences to immediately sell the organization the game-changing and highly effective HIV prevention medicine, lenacapavir, for use in its medical programs worldwide. Despite multiple requests, the company has refused to sell lenacapavir directly to MSF.

Feature story |

27 March 2026

A mother’s journey: Caring for her children with drug-resistant TB

Issue brief |

26 March 2026

EthiopiaNigeriaSouth Sudan

Antimicrobial Resistance in Conflict-Affected Settings: Field Realities, Operational Challenges & Policy Insights

Press release |

24 March 2026

MSF demands sustained investments and political will to end neglect of children with tuberculosis

Interview |

24 March 2026

How TB Treatment Decision Algorithms Help Diagnose Children: A Paediatrician’s Experience

Statement |

20 March 2026

MSF statement at IGWG6

Press release |

19 March 2026

MSF calls on EU to unlock progress in final Pandemic Agreement talks

Letter |

16 March 2026

Open letter: The Critical Medicines Act must deliver equitable, affordable access to medicines for all

Press release |

05 March 2026

DNP+ and MSF welcome the removal of harmful IP provisions in EU-India FTA , but call for continued vigilance

Events |

06 February 2026

MSF statements at WHO Executive Board 158th session

Statement |

16 December 2025

Governments must take concrete actions to ensure equitable access to medical tools for noncommunicable diseases and mental health conditions

Every three minutes, a child dies of tuberculosis (TB), even though treatment is available. In children, under-diagnosis is a major obstacle to effective treatment. New WHO recommendations, including treatment decision algorithms, could change all that.

Photo Credit: Stuart Tibaweswa

Press release |

18 November 2025

MSF findings show WHO algorithms could double the number of children diagnosed and treated for TB

Governments must act now to ensure no child is left behind in the fight against this deadly disease

TUBERCULOSIS

Read more

Photo Credit: Stuart Tibaweswa

Issue brief |

09 April 2026

AfricaKenyaRwandaSouth Africa

Shifting Global Health R&D Funding: Opportunities in a Changing Landscape

Press release |

30 March 2026

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

In an open letter published today, Doctors Without Borders/Médecins Sans Frontières (MSF) called on the US pharmaceutical corporation Gilead Sciences to immediately sell the organization the game-changing and highly effective HIV prevention medicine, lenacapavir, for use in its medical programs worldwide. Despite multiple requests, the company has refused to sell lenacapavir directly to MSF.

Feature story |

27 March 2026

A mother’s journey: Caring for her children with drug-resistant TB

Issue brief |

26 March 2026

EthiopiaNigeriaSouth Sudan

Antimicrobial Resistance in Conflict-Affected Settings: Field Realities, Operational Challenges & Policy Insights

Press release |

24 March 2026

MSF demands sustained investments and political will to end neglect of children with tuberculosis

Interview |

24 March 2026

How TB Treatment Decision Algorithms Help Diagnose Children: A Paediatrician’s Experience

Statement |

20 March 2026

MSF statement at IGWG6

Press release |

19 March 2026

MSF calls on EU to unlock progress in final Pandemic Agreement talks

Letter |

16 March 2026

Open letter: The Critical Medicines Act must deliver equitable, affordable access to medicines for all

Press release |

05 March 2026

DNP+ and MSF welcome the removal of harmful IP provisions in EU-India FTA , but call for continued vigilance

Technical brief |

09 February 2026

Ensuring Collective Efforts Deliver Equitable Access Through the WHO PABS System

Events |

06 February 2026

MSF statements at WHO Executive Board 158th session

Latest News

Genexpert Diagnostic Tests

Technical brief |

02 December 2019

Time for $5: GeneXpert diagnostic tests

The pneumonia vaccine from GSK used for vaccination in refugee camps in Greek islands was made available at a special reduced price of US$9 while its retail price is $168 in Greece.

Photograph by Anna Pantelia

Press release |

02 December 2019

Vaccines

US$262 million subsidy should not go to pharma giants Pfizer and GSK for pneumococcal vaccine

5 min

Technical brief |

02 December 2019

Intellectual property and trade

Briefing note for 31st WIPO Standing Committee on the Law of Patents

Report |

29 November 2019

HIV/AIDS

No time to lose: detect, treat and prevent AIDS

From Guidelines to Reality Accelerating Access to Prevention and Treatment of Paediatric HIV

Technical brief |

28 November 2019

HIV/AIDS

From guidelines to reality: Accelerating access to prevention and treatment of paediatric HIV

Health workers analyzing the images on Lita abdomen in female ward at Nsanje District hospital.

Photograph by Isabel Corthier

Feature story |

28 November 2019

HIV/AIDS

Malawi

HIV: Stories from Malawi

4 min

So called “orange pills” (Amoxicillin), an antibiotic very popular among patients in Ahmed Shah Baba hospital in Kabul. Photograph by Doris Burtscher

Photograph by Doris Burtscher

Opinion article

Opinion article |

21 November 2019

Antimicrobial resistance

India

World Antibiotic Awareness Week: Lack of access

7 min

Together we are MSF

Video |

20 November 2019

Together we are MSF

1 min

AC20 Lives over profit video

Video

Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action

Read more

100 years of insulin

Video |

14 April 2021

100 years of insulin

Read more

A Snapshot of the Access Campaign in 2017

Video

A Snapshot of the Access Campaign

Read more

Video thumbnail

Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action

Video thumbnail

100 years of insulin

Video thumbnail

A Snapshot of the Access Campaign

Our work

Drug-resistant infections

Tropical & neglected diseases

Patents & intellectual property

Research & development